Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nurotron
Hangzhou, Zhejiang, China
- Ownership
- Private
- Employees
- ~400
- Development stage
- Other
01
Overview
Nurotron’s Venus and Enduro cochlear implant systems are commercially available and have restored hearing to over 20,000 users worldwide. The company also has R&D programs in auditory brainstem implants, artificial retina systems, and neurostimulation devices for paralysis. Their cochlear implants are widely used in China and internationally, with strong clinical adoption since 2010.[1][2][3][4]
- Therapeutic areas
- OphthalmologyNeurology
- Modalities
- DeviceNeurostimulation systemImplantable medical device
- Industry
- Implantable Medical Devices
02
Partnerships
University of CaliforniaUniversity of MiamiUniversity of Southern California
Beyond the preview
Go deeper on Nurotron.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nurotron.